InvestorsHub Logo
Followers 1
Posts 52
Boards Moderated 0
Alias Born 10/20/2014

Re: None

Thursday, 07/20/2017 11:40:31 AM

Thursday, July 20, 2017 11:40:31 AM

Post# of 3845
Some RHB-104 patients enrolled in the MAP study are reporting very good results. Over at the biotech investor board they've posted some conversations from current patients found on Crohn's support group forums. Pretty interesting stuff.

http://thebiotechinvestor.freeforums.net/post/33080/thread
http://thebiotechinvestor.freeforums.net/post/33126/thread
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News